Impaired Glucose Tolerance Completed Phase 2 Trials for Metformin (DB00331)

Also known as: Prediabetic State (IGT) / Impaired Glucose Tolerance (IGT) / IGT - Impaired Glucose Tolerance / Glucose tolerance impaired / Impaired Glucose Tolerance (Prediabetes) / Pre-diabetic State / Prediabetic State / Pre-Diabetic / Pre Diabetes / Pre-Diabetes / Pre Diabetic / Prediabetes / Prediabetic / Latent diabetes / Chemical diabetes / Glucose intolerance / Malabsorption of glucose (disorder) / Impaired glucose tolerance (disorder) / Prediabetes (finding) / Borderline diabetes

IndicationStatusPhase
DBCOND0030184 (Impaired Glucose Tolerance)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01068860To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes TherapiesTreatment
NCT02695810The PRE-D Trial: Effect of Dapagliflozin, Metformin and Physical Activity in Pre-diabetesPrevention
NCT01336322Metformin and Sitagliptin in Women With Previous Gestational DiabetesTreatment
NCT05990205Effect of the SCL16A11 Risk Haplotype on Treatments to Prevent Type 2 DiabetesPrevention